Literature DB >> 18329205

Effects of essential oil from Croton tiglium L. on intestinal transit in mice.

Xin Wang1, FaMing Zhang, ZhenXiong Liu, HanZhong Feng, Zhi Bin Yu, Yuanyuan Lu, HuiHong Zhai, FeiHu Bai, YongQuan Shi, Mei Lan, JianPing Jin, DaiMing Fan.   

Abstract

AIM OF THE STUDY: Croton tiglium (Croton tiglium L., Euphorbiaceae) is widely used as a herb for treatment of gastrointestinal disturbances. Previous studies established its purgative and inflammational properties. The present study aimed to investigate the effects of Croton tiglium oil (CO) on intestinal transit in mice.
MATERIALS AND METHODS: Gastrointestinal transit in mice and contractile characteristics of isolated intestinal strips from mice were evaluated. Intestinal inflammation was confirmed by histological examination.
RESULTS: Low dose of CO increased the gastrointestinal transit of charcoal and barium meal as well as the production of fecal pellets in mice. In contrast, high dose exerted inhibitory effects. For normal colonic circular strips, both high and low dose of CO inhibited the contractile frequency. Low doses (0-20 microg/ml) of CO enhanced the phasic contractions, while high doses (>40 microg/ml) reduced them. Colonic longitudinal strips in CO-treated mice were less sensitive to electrical field stimulation than those in control mice. The contraction of colonic longitudinal, colonic and jejunal circular strips in CO-treated mice was more sensitive to atropine than that in control mice.
CONCLUSIONS: CO might modulate gastrointestinal motility and induce intestinal inflammation related to immunological milieu and motor activity. Our findings may highlight the ethno-medical uses of Croton tiglium on intestinal disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18329205     DOI: 10.1016/j.jep.2008.01.023

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  7 in total

Review 1.  Anti-cancer activities of Schedule E1 drugs used in ayurvedic formulations.

Authors:  E N T Vikram; R Ilavarasan; R Kamaraj
Journal:  J Ayurveda Integr Med       Date:  2022-05-31

2.  Antinociceptive and Smooth Muscle Relaxant Activity of Croton tiglium L Seed: An In-vitro and In-vivo Study.

Authors:  Zhen Liu; Wenyuan Gao; Jingze Zhang; Jing Hu
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

3.  Crotonis Fructus and Its Constituent, Croton Oil, Stimulate Lipolysis in OP9 Adipocytes.

Authors:  Mi-Seong Kim; Ha-Rim Kim; Hong-Seob So; Young-Rae Lee; Hyoung-Chul Moon; Do-Gon Ryu; Sei-Hoon Yang; Guem-San Lee; Je-Ho Song; Kang-Beom Kwon
Journal:  Evid Based Complement Alternat Med       Date:  2014-11-11       Impact factor: 2.629

4.  Spatiotemporal Mapping Techniques Show Clozapine Impairs Neurogenic and Myogenic Patterns of Activity in the Colon of the Rabbit in a Dose-Dependent Manner.

Authors:  Susanna Every-Palmer; Roger G Lentle; Gordon Reynolds; Corrin Hulls; Paul Chambers; Helen Dunn; Pete M Ellis
Journal:  Front Pharmacol       Date:  2017-04-24       Impact factor: 5.810

5.  Diterpenoids and C13 Nor-Isoprenoid Identified From the Leaves and Twigs of Croton yanhuii Activating Apoptosis and Pyroptosis.

Authors:  Yue-Qian Li; Bo-Lin Hou; Mei-Jie Wang; Ru-Yue Wang; Xiao-Han Chen; Xu Liu; Dong-Qing Fei; Zhan-Xin Zhang; Er-Wei Li
Journal:  Front Chem       Date:  2022-03-28       Impact factor: 5.221

6.  Croton grewioides Baill. (Euphorbiaceae) Shows Antidiarrheal Activity in Mice.

Authors:  Anne Dayse Soares da Silva; Karoline de Melo E Silva; José Clementino Neto; Vicente Carlos de Oliveira Costa; Hilzeth de Luna F Pessôa; Josean Fechine Tavares; Marcelo Sobral da Silva; Fabiana de Andrade Cavalcante
Journal:  Pharmacognosy Res       Date:  2016 Jul-Sep

7.  Assessment of acute, 14-day, and 13-week repeated oral dose toxicity of Tiglium seed extract in rats.

Authors:  Jun-Won Yun; Euna Kwon; Yun-Soon Kim; Seung-Hyun Kim; Ji-Ran You; Hyoung-Chin Kim; Jin-Sung Park; Jeong-Hwan Che; Sang-Koo Lee; Ja-June Jang; Hyeon Hoe Kim; Byeong-Cheol Kang
Journal:  BMC Complement Altern Med       Date:  2018-09-12       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.